EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harnessing the Power of Artificial Intelligence for Pharmaceutics: From Pharmacokinetics Prediction, Formulation, to Manufacturing

Yuqing Pan, Ruyue Mi, Wei Bian, Zixin Wang, Mingfang Zhao, Zhaoqian Li, Wenkai Zhang, Yaoshuai Zhang, Ziyi Hu, Ning Wang, Buyong Ma

Pharmaceutical Fronts · 01.03.2026 · 08 (01) · e1-e11

DOI: 10.1055/a-2790-6937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.03.2026. Verfasst von Yuqing Pan und 10 weiteren Autor:innen. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Shanghai Municipal Government Science Innovation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug design and optimization remain highly complex processes that must account for pharmacodynamics, pharmacokinetics, toxicity, and manufacturability. Conventional experimental and empirical approaches often struggle to accurately predict pharmacokinetic behavior and therapeutic efficacy, contributing to high attrition rates in late-stage clinical trials. In drug delivery, imprecise targeting and suboptimal formulations can limit therapeutic effectiveness and increase the risk of adverse effects. Artificial intelligence (AI)-driven approaches have demonstrated significant potential in optimizing dosage forms, formulations, and drug bioavailability. Moreover, AI is enabling breakthroughs in pharmaceutical manufacturing by facilitating process optimization and innovation in emerging technologies such as three-dimensional drug printing, microfluidics, and electrospinning. Overall, the integration of AI with advanced pharmaceutical technologies offers transformative opportunities to accelerate drug research and development, enabling more efficient, precise, and personalized pharmaceutical solutions. In this article, we reviewed the application of AI and other advanced technologies in the pharmaceutical industry, focusing on predictions of drug solubility and pharmacokinetics, dosage form design, formulation optimization, bioavailability improvement, and new drug manufacturing technology. We also discussed the opportunities and challenges of AI in the field to fully realize its benefits in further research.

Förderung

  • Natural Science Foundation of China
  • Shanghai Municipal Government Science Innovation

Zitieren

APA

Pan, Y., Mi, R., Bian, W., Wang, Z., Zhao, M., Li, Z., Zhang, W., Zhang, Y., Hu, Z., Wang, N., & Ma, B. (2026). Harnessing the Power of Artificial Intelligence for Pharmaceutics: From Pharmacokinetics Prediction, Formulation, to Manufacturing. Pharmaceutical Fronts, 08(01), e1-e11. https://doi.org/10.1055/a-2790-6937

Vancouver

Pan Y, Mi R, Bian W, Wang Z, Zhao M, Li Z, et al. Harnessing the Power of Artificial Intelligence for Pharmaceutics: From Pharmacokinetics Prediction, Formulation, to Manufacturing. Pharmaceutical Fronts. 2026;08(01):e1-e11. doi:10.1055/a-2790-6937

BibTeX
@article{Pan2026,
  author = {Pan, Yuqing and Mi, Ruyue and Bian, Wei and Wang, Zixin and Zhao, Mingfang and Li, Zhaoqian and Zhang, Wenkai and Zhang, Yaoshuai and Hu, Ziyi and Wang, Ning and Ma, Buyong},
  title = {Harnessing the Power of Artificial Intelligence for Pharmaceutics: From Pharmacokinetics Prediction, Formulation, to Manufacturing},
  journal = {Pharmaceutical Fronts},
  year = {2026},
  volume = {08},
  number = {01},
  pages = {e1--e11},
  doi = {10.1055/a-2790-6937}
}
Kostenlos starten →